Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry

Journal of the American Academy of Dermatology(2021)10.1016/j.jaad.2021.09.016Source: DataRank Database

Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry is a research paper published in Journal of the American Academy of Dermatology (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: hybridTopics (20)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Raed Alhusayen ORCID,John W. Frew ORCID,Sandra Guilbault ORCID,Nancy K. Hills ORCID,John R Ingram ORCID

Live enrichment

PubMed:34537252 PMC:PMC8443529

NIAMS NIH HHS

Grant: K23 AR074531

National Institutes of Health

Grant: 5K23AR074531-03

Microbial Shifts and Immune Dysregulation in Hidradenitis Suppurativa Pathogenesis

hybridLicense: CC BY

publisherhttps://api.elsevier.com/content/article/PII:S0190962221024919?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0190962221024919?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC8443529

Europe_PMChttps://europepmc.org/articles/PMC8443529?pdf=render

https://doi.org/10.1016/j.jaad.2021.09.016

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansHidradenitis SuppurativaBiological TherapySeverity of Illness IndexRegistriesCOVID-19

Keywords

PandemicBiologicsHidradenitis SuppurativaComorbiditiesCovid-19CovidBiological TherapyResearch LetterHumansRegistriesSeverity of Illness IndexCOVID; COVID-19; biologics; comorbidities; hidradenitis suppurativa; pandemic

Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry

FAIR Checklist

Authors (12)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)